Cutler Group’s Fortress Biotech FBIO Stock Holding History

Cutler Group’s Portfolio FBIO Stock Details FBIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-420	Closed	-$1K	–	5564
2021 Q3	$1K	Buy	+420	New	+$20.5K	﹤0.01%	5294

Other funds holding FBIO

CVI Holdings Wilmington, Delaware $116M AUM 5.68% 1-Year Est. Return

Rosalind Advisors Toronto, Ontario, Canada $269M AUM 103.38% 1-Year Est. Return

Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return

ACM

Altium Capital Management New York $47.5M AUM 115.72% 1-Year Est. Return

NCM

Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Hudson Bay Capital Management Stamford, Connecticut $36.8B AUM 42.13% 1-Year Est. Return

SAM

Shikiar Asset Management New York $396M AUM 41.06% 1-Year Est. Return

PAM

PVG Asset Management Golden, Colorado $173M AUM 64.51% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Cutler Group's FBIO Position: Q4 2023 in Review

Cutler Group sold out of Fortress Biotech (FBIO) in Q4 2023, closing a stake of 267 shares — an estimated $1K sold.

Cutler Group first reported a position in FBIO in Q4 2015 and held it in 32 quarters. The position peaked at $60K in Q1 2017. 42 funds tracked by Wall St. Rank hold FBIO as of Q4 2023.

Cutler Group reported no remaining Fortress Biotech position as of Q4 2023 after selling out during the quarter.
Cutler Group sold 267 Fortress Biotech shares in Q4 2023, an estimated $1K.
Cutler Group first reported a position in Fortress Biotech in Q4 2015 and held it in 32 quarters.
Cutler Group's Fortress Biotech position peaked at $60K in Q1 2017.
42 funds tracked by Wall St. Rank held Fortress Biotech as of Q4 2023.

Based on Cutler Group's 13F filing for Q4 2023, filed 18 Jan 2024.